From Analytics to Tumor Boards: An Evidence-Linked Multi-Agent Workflow for Oncology Feature Extraction
Summary
The paper evaluates a configurable multi-agent system (nMAS) for extracting structured oncology data from fragmented clinical documents, achieving high performance compared to a baseline model.
View Cached Full Text
Cached at: 09/01/26, 12:45 PM
# From Analytics to Tumor Boards: An Evidence-Linked Multi-Agent Workflow for Oncology Feature Extraction Source: [https://arxiv.org/html/2608.28974](https://arxiv.org/html/2608.28974) Daniel KangAffiliation:Nimblemind and Nimblemind and Nimblemind and Nimblemind and Nimblemind and Independent Researcher and School of Interactive Computing, Georgia Institute of Technology and Department of Technology Management and Innovation, NYU Tandon School of Engineering, New York University and Florida International University and Duke\-NUS Medical School and Department of Anatomical Pathology, Singapore General Hospital and University of Illinois Urbana\-Champaign and OncoLens and OncoLens and Nimblemind and NimblemindSoorya Ram ShimgekarAffiliation:Shayan VassefAffiliation:Yufan WangAffiliation:Anit Kumar SahuAffiliation:Munmun De ChoudhuryAffiliation:Vedant Das SwainAffiliation:Christian PoellabauerAffiliation:Li Yan KhorAffiliation:Koustuv SahaAffiliation:Robert WojciechowskiAffiliation:Elliot KiddAffiliation:Piyum ZonoozAffiliation:Navin KumarAffiliation: ###### Abstract Clinically relevant oncology information is distributed across heterogeneous, longitudinal documentation, creating substantial abstraction burden and requiring accurate attribution across specimens, tumors, biomarkers, and time points, while manual cancer\-registry abstraction can require 27\.2 minutes per case, highlighting the need for scalable methods that preserve clinical context while converting documentation into structured data\. We evaluate the Nimblemind Multi\-Agent System \(nMAS\), a configurable oncology information\-extraction workflow which extracts clinically relevant structured fields from fragmented oncology documentation\. The extraction task uses a clinician\-informed schema of 328 attributes spanning report metadata, diagnosis, staging, and cancer\-type\-specific information\. nMAS separates clinician\-defined field specifications from model execution and combines complexity\-aware extraction, report\-level consolidation, and source\-grounded validation\. The retrospective evaluation included 230 de\-identified oncology documents from 40 patients and 418 clinician\-reviewed document\-field pairs containing 1,126 non\-empty reference values\. Evaluation focused on fields identified by clinicians as present in the source documents rather than exhaustively annotating all 328 schema fields\. nMAS achieved a rank\-weighted value\-level precision of 82\.6%, recall of 87\.5%, and F1 of 85\.0%, compared with an F1 of 66\.4% for an independently implemented UMA\-style MiniMax M2\.5 comparator\. These findings support the feasibility of using a configurable, source\-grounded extraction workflow to convert fragmented oncology documentation into reusable structured data\. ††proceedings:: Submitted to ML4H 2026:\\mlhtrackname††workshop:Machine Learning for Health \(ML4H\) 2026###### keywords Multi\-Agent Systems, Medical Data Processing, Feature Identification and Enrichment, Data Extraction/Retrieval, Machine Learning Pipeline Optimization
Similar Articles
TumorBoard: Evidence-Grounded Multi-Agent Decision Support for Longitudinal Neuro-Oncology
TumorBoard is a multi-agent decision-support system for longitudinal neuro-oncology that uses a shared longitudinal case state and auditable claim-evidence ledger. It outperforms baselines on a 360-case benchmark, with a safety governor reducing harmful recommendations.
"OncoAgent: A Dual-Tier Multi-Agent Framework for Privacy-Preserving Oncology Clinical Decision Support"
The article introduces OncoAgent, a dual-tier multi-agent framework designed for privacy-preserving clinical decision support in oncology. It details a system architecture that combines corrective RAG, a reflexion safety loop, and dual-tier QLoRA fine-tuning optimized for AMD hardware.
BioInsight: Multi-Agent Orchestration for Interactive Biomedical Knowledge Discovery
BioInsight is a multi-agent system that transforms static biomedical reports into interactive, evidence-centered interfaces by organizing disease-specific evidence through structured artifacts and deterministic citation normalization.
Skill-Augmented AI Agents for Medical Research Analysis: An Exploratory Multi-Model Human Evaluation in an NSCLC Transcriptomic Biomarker Task
This exploratory study evaluates whether augmenting AI agents with a medical research skill package improves the quality of transcriptomic research analysis outputs compared to native AI, using a multi-model human evaluation in an NSCLC biomarker task. Results show a directional but statistically non-significant improvement, highlighting the need for larger, more robust evaluations.
Finding H. pylori in the Fine Print: Evidence-Linked Multi-Agent Case Finding from Gastric Biopsy Reports
This paper introduces the Nimblemind Multi-Agent System (nMAS) for extracting evidence of H. pylori infection from gastric biopsy reports, achieving 98.61% accuracy across 216 feature-case decisions and demonstrating substantial time savings over manual review.